King Wealth Management Group’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-72,338
Closed -$545K 164
2020
Q4
$545K Buy
+72,338
New +$344K 0.13% 89

Other funds holding ORGO

King Wealth Management Group's ORGO Position: Q1 2021 in Review

King Wealth Management Group sold out of Organogenesis Holdings (ORGO) in Q1 2021, closing a stake of 72,338 shares — an estimated $545K sold.

King Wealth Management Group first reported a position in ORGO in Q4 2020 and held it in 1 quarter. The position peaked at $545K in Q4 2020. 101 funds tracked by Wall St. Rank hold ORGO as of Q1 2021.

  • King Wealth Management Group reported no remaining Organogenesis Holdings position as of Q1 2021 after selling out during the quarter.
  • King Wealth Management Group sold 72,338 Organogenesis Holdings shares in Q1 2021, an estimated $545K.
  • King Wealth Management Group first reported a position in Organogenesis Holdings in Q4 2020 and held it in 1 quarter.
  • King Wealth Management Group's Organogenesis Holdings position peaked at $545K in Q4 2020.
  • 101 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2021.

Based on King Wealth Management Group's 13F filing for Q1 2021, filed 14 May 2021.